Steroidal versus nonsteroidal antiandrogens in the management of prostate cancer.
The four antiandrogens currently available (cyproterone acetate, flutamide, nilutamide and bilcalutamide) are reviewed relative to their structure, pharmacology and clinical effect.
Trachtenberg
John
J
Department of Surgery, University of Toronto, Sunnybrook Health Science Centre, Toronto, Ontario.
Farival-Mohseni
Hesam
H
Jewett
Michael A.S.
MA